MarketCap
Facebook
X
TelegramAnnual report 2025
added 05-26-2026
Country |
 USA |
IPO year |
2015 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
10.1 M |
Market Cap[1] |
$ 1.54 M |
EBITDA (LTM) |
$ -10.5 M |
P/E (LTM) |
- |
P/S (LTM) |
0.32 |
EPS (LTM) |
1.68 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Celcuity
CELC
|
$ 88.28 | -4.53 % | $ 4.13 B | Nasdaq Global Select Market | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Co-Diagnostics
CODX
|
$ 5.63 | -2.26 % | $ 7.49 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 21.01 | -2.73 % | $ 609 M | Nasdaq Global Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 19.15 | -1.79 % | $ 589 M | Nasdaq Global Market | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Guardant Health
GH
|
$ 125.61 | -5.6 % | $ 15.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Interpace Biosciences
IDXG
|
$ 1.67 | -6.7 % | $ 7.39 M | Nasdaq Global Select Market | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Illumina
ILMN
|
$ 162.32 | -3.42 % | $ 25.2 B | Nasdaq Global Select Market,SPB | USA |
 |
CareDx, Inc
CDNA
|
$ 22.25 | -3.76 % | $ 1.19 B | Nasdaq Global Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
ICON Public Limited Company
ICLR
|
$ 149.45 | -2.19 % | $ 11.7 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Lantheus Holdings
LNTH
|
$ 100.98 | -1.79 % | $ 6.82 B | Nasdaq Global Select Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
NeoGenomics
NEO
|
$ 10.9 | -3.63 % | $ 1.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Natera
NTRA
|
$ 215.31 | -3.06 % | $ 29.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 181.34 | -2.4 % | $ 8.99 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Pacific Biosciences of California
PACB
|
$ 1.45 | -11.04 % | $ 435 M | Nasdaq Global Select Market,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 454.25 | -0.97 % | $ 13.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 154.33 | -2.22 % | $ 23.8 B | NYSE,SPB |  Schweiz |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 4.57 | -2.56 % | $ 423 M | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 19.14 | -3.09 % | $ 428 M | Nasdaq Global Select Market | USA |
 |
Personalis
PSNL
|
$ 10.75 | -11.16 % | $ 959 M | Nasdaq Global Select Market | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 26.11 | 0.46 % | $ 24.8 B | NYSE |  Niderland |
 |
Senseonics Holdings
SENS
|
$ 6.67 | -4.85 % | $ 278 M | NYSE American | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Biomerica
BMRA
|
$ 2.12 | -1.17 % | $ 4.87 M | Nasdaq Capital Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 265.15 | 1.6 % | $ 22.1 B | NYSE,SPB | USA |
 |
Twist Bioscience Corporation
TWST
|
$ 69.22 | -6.37 % | $ 4.14 B | Nasdaq Global Select Market,SPB | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 472.8 | -1.91 % | $ 178 B | NYSE,SPB | USA |
 |
Trinity Biotech plc
TRIB
|
$ 0.67 | -2.43 % | $ 241 M | Nasdaq Global Select Market | Irlanda |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Waters Corporation
WAT
|
$ 365.36 | -2.95 % | $ 21.8 B | NYSE,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 8.9 | -2.41 % | $ 1.93 B | Nasdaq Global Select Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 200.29 | 2.13 % | $ 22.2 B | NYSE,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.